newsAimmune Therapeutics' PALFORZIA® has been approved by the European Commission as…
5 January 2021 | By Victoria Rees (European Pharmaceutical Review)
Aimmune Therapeutics' PALFORZIA® has been approved by the European Commission as a treatment for peanut allergy.